Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FPNEC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,364
Award facts
- Contract value 100% obligated
- $10,363.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,363.90 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units). This competitive delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Vraylar, a medication used in the treatment of psychiatric conditions, supports the Defense Health Agency's medical supply requirements for military personnel and veterans.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare systems globally. The company's participation in the DLA's Pharmaceutical Prime Vendor program reflects its established capability to fulfill federal procurement requirements through competitive processes and positions it as a primary source for pharmaceutical commodities across multiple therapeutic domains serving the Department of Defense medical infrastructure.
Quick answers
Who was awarded contract SPE2DB25FPNEC?
SPE2DB25FPNEC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FPNEC worth?
The government has obligated $10,364 on SPE2DB25FPNEC.
Is contract SPE2DB25FPNEC an order under another contract?
Yes. SPE2DB25FPNEC is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB25FPNEC competed?
The extent of competition for SPE2DB25FPNEC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award